Cite
HARVARD Citation
Mohamed, M. et al. (2018). Use of Early Clinical Trial Data to Support Thorough QT Study Waiver for Upadacitinib and Utility of Food Effect to Demonstrate ECG Assay Sensitivity. Clinical pharmacology & therapeutics. 103 (5), pp. 836-842. [Online].